In Vitro and In Vivo Evaluation of Hydrophilic C60(OH)10/2-Hydroxypropyl-β-cyclodextrin Nanoparticles as an Antioxidant
In Vitro and In Vivo Evaluation of Hydrophilic C60(OH)10/2-Hydroxypropyl-β-cyclodextrin Nanoparticles as an Antioxidant
复制标题
DOI:
10.1016/j.xphs.2016.04.033
复制
发表时间:
2016-09-01
影响因子:
3.8
通讯作者:
Hirayama, Fumitoshi
中科院分区:
文献类型:
--
作者:
Iohara, Daisuke;Umezaki, Yoshitaka;Hirayama, Fumitoshi
The objective of this study was to assess the antioxidant ability of C-60(OH)(10)/2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD) nanoparticles, by comparing their scavenging ability for reactive nitrogen species, their cytoprotective effects under conditions of oxidative stress, and their therapeutic effects against diseases that are induced by oxidative stress. The C-60(OH)(10)/HP-beta-CD nanoparticles had a higher scavenging activity against nitric acid and peroxynitrite (ONOO-) than the other antioxidants such as ascorbic acid, trolox, and edaravone. The cytoprotective effect of C-60(OH)(10)/HP-beta-CD nanoparticles was examined on HeLa and HepG2 cells by monitoring the percentage of cell death induced by H2O2. Treatment with C-60(OH)(10)/HP-beta-CD nanoparticles resulted in an increase in cell viability, due to the suppression of the oxidative stress. Furthermore, the nanoparticles had a high cytoprotective effect, compared with other polyhydroxylated C-60 (C-60(OH)(24) and C-60(OH)(40)). The C-60(OH)(10)/HP-beta-CD nanoparticles were intravenously administered to mice with a liver injury induced by an over dose of acetaminophen. Levels of alanine transaminase and aspartate transaminase were essentially the same as those of normal mice and the survival rate was also prolonged by the intravenous administration of the C-60(OH)(10)/HP-beta-CD nanoparticles. The results indicate that C-60(OH)(10)/HP-beta-CD nanoparticles are a promising antioxidant for use in the treatment of diseases caused by oxidative stresses. (C) 2016 Published by Elsevier Inc. on behalf of the American Pharmacists Association.